We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Module for Enhanced Mass Spectrometry Applications Combines Capillary Electrophoresis with Electron Spray Ionization

By LabMedica International staff writers
Posted on 27 Jun 2011
A new system for separation and characterization of proteins and other large molecules combines capillary electrophoresis (CE) with advanced electrospray ionization (ESI) into a single instrument designed for use with a mass spectrometer.

The new instrument is the Beckman Coulter, Inc. More...
(Brea CA, USA) CESI 8000 High-Performance Separation-ESI Module. The module incorporates Beckman's OptiMS technology and is the first commercial CESI sprayer combined with new capillary electrophoresis instrumentation specifically designed for mass spectrometry (MS).

OptiMS Technology integrates an intrinsically low flow CE separation with ESI in a single, dynamic process that takes place within a capillary. To achieve CESI, the distal end of the capillary is porous to ion flow, allowing the electrophoresis circuit to be bridged and ESI to be initiated within the same device.

The CESI-MS method is capable of generating separations of peptides with a high peak capacity, allowing the analysis of very complex samples at the proteome level. The ultra-low flow rates used by CE effectively reduce ion suppression and make it possible to detect post-translational modifications such as phosphorylation and sialylation, which typically hamper efficient ionization. High-separation efficiency and sensitivity permit the detection of peptides present in trace amounts. The selectivity of CE in front-end separation further enables the characterization of intact proteins, their isoforms, cleaved fragments, and complexes.

The CESI 8000 system also allows fast and efficient separations of drugs, drug metabolites, organic acids, amino acids, low molecular weight amines, peptides, nucleic acids, and nucleosides.

"The CESI 8000 was developed in collaboration with mass spectrometry researchers who work in a variety of applications and who sought to expand the range of analytes detected while improving overall assay sensitivity," said Jeff Chapman, director of Beckman Coulter Discovery Products. "The result is a front-end separation system that generates data complementary to HPLC (high pressure liquid chromatography) and provides scientists with important, previously unavailable information."

Related Links:

Beckman Coulter, Inc.




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Manual Pipetting Aid
Pipette Controllers macro
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.